Omeprazole — Medication Guide, Uses & Safety — Uses, Dosage & Side Effects | MyMedicPlus

Omeprazole is a proton pump inhibitor (PPI) that significantly and durably suppresses gastric acid production. It is one of the most widely prescribed drugs in the world — consistently ranking in the top 5 by prescription volume globally — and is a key member of a drug class that has transformed the management of acid-related gastrointestinal disorders since its introduction in 1989. Omeprazole is available as delayed-release capsules and tablets, and as an intravenous injection for hospital use. At low doses (10–20 mg), it is available without prescription in many countries for short-term self-treatment of heartburn and acid indigestion. At prescription doses (20–40 mg once daily), it is used for the definitive treatment of gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome (a condition of excessive acid secretion), and as part of H. pylori eradication regimens. As a prodrug, omeprazole is absorbed from the small intestine and is activated within the acidic secretory canaliculi of gastric parietal cells — meaning delayed-release formulations must not be crushed or chewed as this destroys the acid-resistant coating necessary for correct absorption. Other PPIs in the same class include pantoprazole, lansoprazole, esomeprazole (the S-enantiomer of omeprazole), and rabeprazole.

Omeprazole is prescribed for the treatment and management of a range of acid-related gastrointestinal conditions. Primary on-label indications include gastroesophageal reflux disease (GERD) — both symptom relief and healing of erosive esophagitis (grades A–D); maintenance of GERD remission; gastric ulcer treatment (typically 4–8 weeks); duodenal ulcer treatment (typically 4 weeks, shorter than gastric ulcers); Helicobacter pylori eradication — as part of dual, triple, or quadruple antibiotic combination therapy (e.g. omeprazole 20–40 mg + clarithromycin + amoxicillin twice daily for 7–14 days); Zollinger-Ellison syndrome (rare condition from a gastrin-secreting tumor, requiring high doses); and NSAID-induced peptic ulcer treatment and prevention in high-risk patients on regular NSAIDs or aspirin. OTC use: short-term (up to 14 days) relief of frequent heartburn (at least 2 days per week). Omeprazole is prescribed by general practitioners, gastroenterologists, and prescribed or recommended by pharmacists for appropriate OTC indications. It is also used prophylactically in critically ill ICU patients to prevent stress ulceration, and during anticoagulant therapy in patients with gastric risk factors.

Omeprazole is a benzimidazole prodrug that requires an acidic environment for activation. After absorption into the bloodstream, it accumulates in the secretory canaliculi of the gastric parietal cells — the specialized stomach cells responsible for hydrochloric acid secretion. In this highly acidic environment (pH less than 2), omeprazole is protonated and converted to its active sulfenamide form, which then forms a covalent (irreversible) disulfide bond with cysteine residues on the H+/K+ ATPase enzyme (the gastric proton pump). This enzyme is the final step in the acid secretion pathway — it actively pumps hydrogen ions (H+) out of parietal cells into the stomach lumen in exchange for potassium ions. By irreversibly binding and inactivating the proton pump, omeprazole dramatically reduces acid secretion by 80–95%. Because the bond is irreversible, acid suppression persists for 18–24 hours even after the drug has been cleared from the bloodstream. Recovery of acid secretion requires synthesis of new proton pump proteins, which takes 18–24 hours. For maximum efficacy, omeprazole should be taken 30–60 minutes before a meal — eating stimulates proton pump activation, making them maximally accessible to omeprazole. The full antisecretory effect builds gradually over 3–5 days of regular dosing as all proton pumps are progressively inactivated.

OTC dose: omeprazole 10–20 mg once daily for up to 14 days for self-treatment of frequent heartburn — do not use for more than 14 consecutive days without medical guidance. Prescription doses: GERD (symptom relief and maintenance): 20 mg once daily for 4–8 weeks; severe GERD or erosive esophagitis: 40 mg once daily for up to 8 weeks; gastric ulcer: 20–40 mg once daily for 4–8 weeks; duodenal ulcer: 20 mg once daily for 4 weeks; H. pylori eradication: 20–40 mg twice daily as part of triple or quadruple therapy for 7–14 days; Zollinger-Ellison syndrome: starting dose 60 mg daily, titrated upward as required (doses up to 120 mg/day in divided doses may be needed); NSAID gastroprotection: 20 mg once daily. Always take omeprazole 30–60 minutes before the first meal of the day on an empty stomach for optimal efficacy. Swallow delayed-release capsules whole — do not crush, break, or chew. Capsule contents can be opened and mixed with small amounts of apple juice or yogurt if swallowing is difficult — consume immediately without chewing the granules. IV omeprazole is used in hospital settings for severe bleeding ulcers and in patients unable to take oral medication.

Omeprazole is generally well tolerated for short-term use. Common side effects (occurring in 1–10% of users) include headache, nausea, abdominal pain, diarrhea, constipation, and flatulence — these are usually mild and transient. Long-term PPI use (exceeding 1 year) is associated with several clinically significant adverse effects that require monitoring. Hypomagnesemia (low blood magnesium levels) can occur with prolonged use — symptoms include muscle cramps, cardiac arrhythmias, and tetany; serum magnesium should be monitored in patients on long-term PPI therapy or those on medications known to lower magnesium (e.g. diuretics). Vitamin B12 deficiency: long-term acid suppression impairs B12 absorption from dietary protein by reducing pepsin activity — annual B12 level monitoring is recommended for patients on PPIs for more than 2 years. Increased fracture risk: multiple epidemiological studies have associated long-term high-dose PPI use with a modest increase in hip, wrist, and spine fractures, particularly in elderly patients — ensure adequate calcium and vitamin D intake. Clostridioides difficile infection: gastric acid normally kills many ingested bacteria; its suppression by PPIs is associated with approximately 1.7-fold increased risk of C. diff diarrhea (particularly in those also taking antibiotics or hospitalized). Fundic gland polyps (benign gastric mucosal changes) can develop with prolonged PPI use. Rare: acute interstitial nephritis (drug hypersensitivity affecting the kidneys — discontinue if occurring).

Omeprazole and all PPIs may mask the early warning symptoms of gastric cancer — new-onset or persistent epigastric symptoms in patients aged over 55 years, or those with alarm features (weight loss, dysphagia, progressive vomiting, GI bleeding, persistent anemia), must be investigated with upper GI endoscopy to exclude malignancy before prescribing long-term PPI therapy. Long-term PPI use should be regularly reassessed and the lowest effective dose used — many patients are on PPIs without an ongoing clinical indication. A stepdown trial or attempt to stop should be made annually under medical supervision. Clinically important drug interactions: omeprazole significantly reduces the antiplatelet effectiveness of clopidogrel (Plavix) by approximately 45% — this occurs because omeprazole inhibits CYP2C19, an enzyme essential for activating clopidogrel from prodrug to active form; pantoprazole is the preferred PPI in patients on clopidogrel, as it has less CYP2C19 inhibitory effect. Omeprazole increases blood levels of methotrexate (risk of toxicity — temporary PPI discontinuation may be required for high-dose methotrexate). Some HIV antiretroviral drugs (atazanavir, rilpivirine, nelfinavir) require gastric acid for absorption — PPIs substantially reduce their levels and should not be co-administered. Omeprazole reduces absorption of drugs that require gastric acid: ketoconazole, itraconazole, iron salts, mycophenolate mofetil, erlotinib, and certain tyrosine kinase inhibitors. Omeprazole should be taken at least 30–60 minutes before food for optimal efficacy.